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Supplemental Fig 1.- Hypothalamic gene expression of orexigenic (Npy and Agrp) and anorexigenic 1 
(Cart and Pomc) neuropeptides of ob/ob and C57BL6/J mice subcutaneously treated with oxytocin 2 
(50nmol/day) or vehicle (saline) during 14 days, considering the levels in the C57BL6/J saline- 3 
treated group as a log2 fold change of 0 (A) or 100% (B), N=7-8. **p<0.01, ***p<0.001 vs. C57 Sal; 4 
†p<0.05, ††p<0.01, †††p<0.001 vs. C57 Oxt. 5 
Supplemental Fig 2.- Food intake-dependent and –independent effects of oxytocin, as determined 6 
by using a pair-fed control group.   Ob/ob mice were treated with vehicle (saline), oxytocin 7 
(50nmol/day) or vehicle (saline), but receiving the same amount of food as oxytocin-treated mice 8 
(PF, pair-fed group) during 14 days. (A) Delta body composition between the beginning and the 9 
end of the treatment measured by magnetic resonance imaging, N=6-20. (B) Epididymal white 10 
adipose tissue (eWAT) weight, N=6-7. (C) eWAT gene expression of lipolytic (Hsl), lipogenic (Fasn) 11 
lipid uptake (Lpl) and glyceroneogenic (Pepck) enzymes, as well as of the oxytocin receptor (Oxtr), 12 
considering the levels in the ob/ob Sal group as 100%, N=6-7. (D) FASN activity in eWAT, N=6-7. (E) 13 
Expression of the macrophage marker Emr1 in eWAT, considering the levels in the ob/ob Sal group 14 
as 100%, N=6. (F) Representative merged immunofluorescence images of the macrophage marker 15 
MAC-2 in the red channel and the nuclear marker, Hoechst 33258 in the blue channel and 16 
quantification of the immunofluorescence in percent of MAC-2 positive cells over all cells present 17 
on the slice, scale white bar: 100 um, N=6-7. (G) Representative hepatic hematoxylin and eosin 18 
staining from animals with the different treatments, scale black bar: 100 um. (H) Quantification of 19 
hepatic triglyceride content, N=6-7. (I) Representative hepatic oil red O staining from animals with 20 
the different treatments, scale black bar: 100 um. (J) Hepatic gene expression of gluconeogenic 21 
(G6pc, Fbp1 and Pepck) and glycolytic (Gck, Pfkb1 and Pklr)  enzymes, N=6-7. (K-L) Glycemia (K, 22 
N=6-17) and insulinemia (L, N=6-7) during a glucose tolerance test. *p<0.05, **p<0.01, ***p<0.001 23 
vs. ob/ob Sal; †p<0.05, ††p<.0.01 vs. ob/ob Oxt. 24 
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Supplemental Fig 3 Hepatic glycogen content and related genes in C57BL6/J and ob/ob mice. (A-B) 25 
Quantification of hepatic glycogen content, (C-D) Hepatic gene expression of glycogen synthase 26 
(Gys2) and phosphorylase (Pygl). Mice were ob/ob (A and C) or C57BL6/J (B and D) subcutaneously 27 
treated with oxytocin (50nmol/day) or vehicle (saline) during 14 days. N=6-8. *p<0.05, 28 
***p<0.001.. 29 
Supplemental Fig 4 Oxtr mRNA expression and plasma oxytocin levels in C57BL6/J and ob/ob mice. 30 
(A) Oxtr levels in different mouse tissues, according to the BioGPS database (24). (B) eWAT gene 31 
expression of Oxtr in saline-treated C57BL6/J and ob/ob mice, considering the levels in the 32 
C57BL6/J group as 100%, N=7-8. (C) Plasma oxytocin levels of saline-treated C57BL6/J and ob/ob 33 
mice, N=5-6. ***p<0.001.  34 
Supplmental Table 1.- Sequence of primers used for the Real Time PCR.  35 
 36 
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Sup Table-Primers 
 
Genes Forward  Reverse 
White adipose tissue genes 
Hsl (official name Lipe) GGAGCACTACAAACGCAACGA CCACCGGTAAAGAGGGAACTG 
Fasn GCCAACCGGCTCTCTTTCTT GGCTGTGTCCAGGGCAAT 
Lpl TTCCAGCCAGGATGCAACA CCACGTCTCCGAGTCCTCTCT 
Oxtr CATCACCTTCCGCTTCTACGG ATGCCCACCACCTGCAAGTA 
Emr1 (also known as F4/80) CAGATACAGCAATGCCAAGCA GATTGTGAAGGTAGCATTCACAAGTG 
Liver genes 
G6pc GGAGTCTTGTCAGGCATTGCT CGGAGGCTGGCATTGTAGAT 
Fbp1 GCACTCTGGTATATGGAGGGATCT AGCAGCCGCAGCTTTCC 
Pepck1(official name Pck1) CCACAGCTGCTGCAGAACAC GAAGGGTCGCATGGCAAA 
Pfkb1 TGATCTGTCACCAGGCTGTCA AGGGCAGCTCATCTGAACTTTT 
Pklr GAACCATGAAGGCGTGAAGAA CCCCGAGCCACCATGAT 
Gck TGGATGGCTCCGTGTACAAG GATTTCGCAGTTGGGTGTCA 
Gys2 GAGTCCTTATCCAGGCTTAATTTCC GGCAGGCATGATGAAAAACA 
Pygl CGGTGAACGGTGTAGCAAAGA CTAGCTCGCTGAAGTCCTTGAAT 
Hypothalamic genes 
Cart CTGCAATTCTTTCCTCTTGAAGTG GGGAATATGGGAACCGAAGGT 
Agrp CCGCTTCTTCAATGCCTTTT AGGTGCGACTACAGAGGTTCGT 
Pomc GCAGAGGCAAACAAGATTGGA CAGAGAGCTGCCTTTCCGCGACAG 
Npy AAAACGCCCCCAGAACAAG CGGGAGAACAAGTTTCATTTCC 
Housekeeping gene Rps29 GCAAATACGGGCTGAACATGT TCCAACTTAATGAAGCCTATGTCCTT 
 
Sequence of primers used for the Real Time PCR.  
